Toggle light / dark theme

Creating a world where no woman has to die giving life — temitayo erogbogbo, global advocacy director, MSD for mothers, merck sharp & dohme.


Mr. Temitayo (Tayo) Erogbogbo, is Global Advocacy Director of MSD for Mothers (https://www.msdformothers.com/), at Merck Sharp & Dohme.

Tayo has two decades of combined private sector and international development experience, 13 years of which was spent in the pharmaceutical industry in multiple roles across community relations, government affairs, marketing and sales.

As the Global Advocacy Director of MSD for Mothers, Tayo is responsible for global and national strategic partnerships and programs to bring about policies and practice changes to improve maternal health care, and strengthen health systems, particularly where private sector approaches can be leveraged for greater impact.

Prior to MSD for Mothers, Tayo led the establishment of an adolescents and youth constituency at The Partnership for Maternal, Newborn and Child Health (PMNCH), a multi-constituency partnership hosted by the World Health Organization, to advocate for better sexual, reproductive, maternal, newborn, child, and adolescent health policies and services at global, regional, and national levels. Additionally, he contributed to the development of the Global Strategy for Women’s, Children’s, and Adolescents’ Health 2016–2030.

Previously, in collaboration with multi-sectoral partners in Nigeria, he contributed to the passage of the National Health Bill, the development of the National Gender Policy Guidelines and the passage of Violence Against Person’s Prohibition in support of gender equality. Tayo also spearheaded Abbott’s HIV patient relations function within Europe, developing services to support people living with HIV by partnering with community organizations. He advocated for anti-retroviral drug access across Africa and developed a health care professional (HCP) train-the-trainer program that has educated over 3,000 HCPs.

Tayo earned a BSc in Management Sciences from Loughborough University, and a MSc in Information Technology for Management from Coventry University.

Tayo is also an elite athlete in the Triple Jump with a Bronze medal at the European U23 Championships.

Imagine a world in which smart packaging for supermarket-ready meals updates you in real-time to tell you about carbon footprints, gives live warnings on product recalls and instant safety alerts because allergens were detected unexpectedly in the factory.

But how much extra energy would be used powering such a system? And what if an accidental alert meant you were told to throw away your food for no reason?

These are some of the questions asked by team of researchers, including a Lancaster University Lecturer in Design Policy and Futures Thinking, who—by creating objects from a “smart” imaginary new world—are looking at the ethical implications of using artificial intelligence in the food sector.

China’s zero-COVID-19 policy is showing strain as health authorities struggle to contain the growing spread of the Delta variant.
At least 1,000 locally-transmitted infections have been reported since mid-October in 20 provinces, prompting strict quarantine periods and area-specific lockdowns.
The onset of winter in China’s north is also helping disperse the disease.
Al Jazeera’s Katrina Yu reports from Beijing, China.

- Follow us on Twitter: https://twitter.com/AJEnglish/
- Find us on Facebook: https://www.facebook.com/aljazeera/
- Check our website: https://www.aljazeera.com/

#China #COVID #Delta

I think intelligent tool making life is rare but there is plenty of room for those far, far in advance of us. Robert Bradbury, who thought up M-Brains, said he did not think truly hyper advanced entities would bother communicating with us. Being able to process the entire history of human thought in a few millionths of a second puts them further away from us than we are from nematodes. But then that might not be giving them credit for their intelligence and resources, as they might wish to see how well their simulations have done compared to reality.


Foresight Intelligent Cooperation Group.

2021 program & apply to join: https://foresight.org/intelligent-cooperation/

Anders Sandberg, Oxford University.

Game Theory of Cooperating with Extraterrestrial Intelligence and Future Civilizations.

Anders Sandberg’s research at the Future of Humanity Institute centres on management of low-probability high-impact risks, estimating the capabilities of future technologies, and very long-range futures. Anders is a Senior Research Fellow on the ERC UnPrEDICT Programme. Topics of particular interest include global catastrophic risk, cognitive biases, cognitive enhancement, collective intelligence, neuroethics, and public policy. He is research associate to the Oxford Uehiro Centre for Practical Ethics, and the Oxford Centre for Neuroethics. He is on the advisory boards of a number of organisations and often debates science and ethics in international media. Anders has a background in computer science, neuroscience and medical engineering. He obtained his Ph.D. in computational neuroscience from Stockholm University, Sweden, for work on neural network modelling of human memory.

JOIN VISION WEEKEND 2021 (US & France, Dec 2021)

Where: Starting at the Internet Archive, a rocket company, and ship in San Francisco on Dec 4 & 5 culminating at a laboratory for the future disguised as a stunning castle outside of Paris on Dec 11 & 12.

EVP, patient advocacy & engagement, national patient advocate foundation.


Gwen Darien is Executive Vice President for Patient Advocacy and Engagement, at the National Patient Advocate Foundation (https://www.npaf.org/), an organization with a mission of bringing patient voices to health system delivery reform, developing and driving initiatives promoting equitable access to affordable quality health care, and prioritizing the patient voice in health system delivery reform to achieve person-centered care. She is also Executive Vice President at their sister organization, Patient Advocate Foundation (https://www.patientadvocate.org/), a national non-profit organization which provides case management services and financial aid to Americans with chronic, life threatening and debilitating illnesses.

Gwen is a longtime patient advocate who has played leadership roles in some of the country’s preeminent nonprofit organizations.

As a three-time cancer survivor herself, Gwen came into cancer advocacy expressly to change the experiences and outcomes for the patients who came after her and to change the public dialogue about cancer and other life-threatening illnesses.

In 2,005 Gwen started the first stand-alone advocacy entity in a professional cancer research organization, at the American Association for Cancer Research, launching CR magazine – a magazine for people with cancer and those who care for them. Later, she served as the executive director of the Samuel Waxman Cancer Research Foundation; director of The Pathways Project; and executive vice president of programs and services at the Cancer Support Community, where in each role, Gwen championed placing patients at the center of health system change, whether it was for research, public policy or direct services.

While serving as the chair or on the board of a wide range of program committees and workshop faculties, including the Community Engagement in Genomics Working Group of the National Human Genome Research Institute; a member of the US Pharmacopeia Board of Trustees; and as the past chair of PCORI’s Patient Engagement Advisory Panel, Gwen also continues to write about her experiences. Her most recent piece, Transformation: My Experience as a Patient and an Advocate in Three Chapters appeared in the National Academy of Medicine Perspectives (https://nam.edu/transformation-my-experience-as-a-patient-and-an-advocate-in-three-chapters/).

It’s been a tumultuous 12 months for mainland China’s richest. Shifts in government policy covering the education and tech industries, along with worries about real estate debt, led to many of the country’s largest private-sector companies experiencing steep share declines. A government push to promote “common prosperity” saw tycoons and tech companies announce billions of dollars in donations to social causes.

Yet overall, China’s 100 Richest saw their collective net worth rise from last year’s list. Their total wealth increased to $1.48 trillion from $1.33 trillion a year earlier. Among the biggest gainers were those who benefited from increased sales at companies tied to green energy industries in which China is a global leader, such as lithium-ion batteries. China, the world’s largest auto market, also leads the world in EV sales. The minimum net worth to make the top 100 rose to $5.74 billion from $5.03 billion a year ago.

The second-biggest increase in wealth went to Robin Zeng, chairman of battery-maker Contemporary Amperex Technology, whose fortune increased to $50.8 billion from $20.1 billion last year. That earned him the No. 3 spot on this year’s list.

This type of cell could lead to an unlimited cell division in human cells aka a forever lifespan 😃 #immortality


“The sequencing and posting of the HeLa genome brought into sharp relief important ethical and policy issues,” said Dr. Collins. “To understand the family’s perspectives, we met with them face to face three times over four months, and listened carefully to their concerns. Ultimately, we arrived at a path forward that respects their wishes and allows science to progress. We are indebted to the Lacks family for their generosity and thoughtfulness.”

The HeLa Genome Data Use Agreement

The new controlled access policy for full genome sequence data from HeLa cells will give the Lacks family the ability to have a role in work being done with the HeLa genome sequences and track any resulting discoveries. Under the policy, biomedical researchers who agree to abide by terms set forth in the HeLa Genome Data Use Agreement will be able to apply to NIH for access to the full genome sequence data from HeLa cells. Along with representatives from the medical, scientific, and bioethics communities, two representatives of the Lacks family will serve on NIH’s newly formed, six-member working group that will review proposals for access to the HeLa full genome sequence data. In addition, NIH-funded researchers who generate full genome sequence data from HeLa cells will be expected to deposit their data into a single database for future sharing through this process. The database study page will be accessible after the embargo lifts at this url: http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000640.v1.p1. Other investigators will be encouraged to respect the wishes of the family and do the same. Importantly, all researchers who use or generate full genomic data from HeLa cells will now be asked to include in their publications an acknowledgement and expression of gratitude to the Lacks family for their contributions.

The strategy outlines how AI can be applied to defence and security in a protected and ethical way. As such, it sets standards of responsible use of AI technologies, in accordance with international law and NATO’s values. It also addresses the threats posed by the use of AI by adversaries and how to establish trusted cooperation with the innovation community on AI.

Artificial Intelligence is one of the seven technological areas which NATO Allies have prioritized for their relevance to defence and security. These include quantum-enabled technologies, data and computing, autonomy, biotechnology and human enhancements, hypersonic technologies, and space. Of all these dual-use technologies, Artificial Intelligence is known to be the most pervasive, especially when combined with others like big data, autonomy, or biotechnology. To address this complex challenge, NATO Defence Ministers also approved NATO’s first policy on data exploitation.

Individual strategies will be developed for all priority areas, following the same ethical approach as that adopted for Artificial Intelligence.

The policy applies even if the violation occurred outside a group.


Facebook is taking new steps to crack down on groups users who break its rules, even when they have done so in other parts of the app.

Under the new policy, Facebook will downrank content posted in groups by users who have broken its rules even if they have done so elsewhere on the company’s platform. The new rule will apply to any group member who has had a post removed for violating one of Facebook’s Community Standards in the previous 90 days. Those who have had multiple posts removed will have “more severe” demotions.

“This measure will help reduce the ability of members who break our rules from reaching others in their communities, and builds on the existing restrictions placed upon members who violate Community Standards,” Facebook wrote in a statement. The company notes that it already has policies that from people who repeatedly break rules within.

This post is a collaboration with Dr. Augustine Fou, a seasoned digital marketer, who helps marketers audit their campaigns for ad fraud and provides alternative performance optimization solutions; and Jodi Masters-Gonzales, Research Director at Beacon Trust Network and a doctoral student in Pepperdine University’s Global Leadership and Change program, where her research intersects at data privacy & ethics, public policy, and the digital economy.

The ad industry has gone through a massive transformation since the advent of digital. This is a multi-billion dollar industry that started out as a way for businesses to bring more market visibility to products and services more effectively, while evolving features that would allow advertisers to garner valuable insights about their customers and prospects. Fast-forward 20 years later and the promise of better ad performance and delivery of the right customers, has also created and enabled a rampant environment of massive data sharing, more invasive personal targeting and higher incidences of consumer manipulation than ever before. It has evolved over time, underneath the noses of business and industry, with benefits realized by a relative few. How did we get here? More importantly, can we curb the path of a burgeoning industry to truly protect people’s data rights?

There was a time when advertising inventory was finite. Long before digital, buying impressions was primarily done through offline publications, television and radio. Premium slots commanded higher CPM (cost per thousand) rates to obtain the most coveted consumer attention. The big advertisers with the deepest pockets largely benefitted from this space by commanding the largest reach.